Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$149.52+3.19 (+2.18%)
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Deferred Tax Assets — Net by Year
Deferred Tax Assets — Net ($M) ($M)
Merck Deferred Tax Assets — Net: $6,733M in FY2025, up 27.8% from a year earlier. That is the highest of the 10 years on record here.
Latest, FY2025
6,733
Period ended Dec 31, 2025
Change on a year earlier
+27.8%
5,270 in FY2024
History
10 years
Since FY2016
Sources
9
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Form 10-K Taxes on Income Note.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Deferred Tax Assets — Net ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6,733 | +27.8% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 5,270 | +30.0% | Form 10-K (filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 4,055 | +34.5% | Form 10-K (filed 2025-02-25) ↗ |
| FY2022 | Dec 31, 2022 | 3,015 | +32.8% | Form 10-K (filed 2024-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 2,270 | -6.7% | Form 10-K (filed 2023-02-24) ↗ |
| FY2020 | Dec 31, 2020 | 2,433 | +8.1% | Form 10-K (filed 2022-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 2,251 | +27.2% | Form 10-K (filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 1,770 | -11.3% | Form 10-K (filed 2020-02-26) ↗ |
| FY2017 | Dec 31, 2017 | 1,995 | -35.8% | Form 10-K (filed 2019-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 3,109 | – | Form 10-K (filed 2018-02-27) ↗ |
Cite this data
StockData. (2026). Merck Deferred Tax Assets — Net ($M), annual FY2016–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/tax-dta-net
See every metric in the Merck KPI table. Data updated Oct 26, 2026.